147 related articles for article (PubMed ID: 38183563)
21. Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.
Norman R; Kemmler G; Viney R; Pickard AS; Gamper E; Holzner B; Nerich V; King M
Value Health; 2016 Dec; 19(8):1033-1038. PubMed ID: 27987630
[TBL] [Abstract][Full Text] [Related]
22. Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score.
Klapproth CP; Fischer F; Rose M; Karsten MM
J Clin Epidemiol; 2022 Dec; 152():101-109. PubMed ID: 36162712
[TBL] [Abstract][Full Text] [Related]
23. Estimation of Health-Related Utilities for
Soare IA; Leeuwenkamp O; Longworth L
Pharmacoecon Open; 2021 Dec; 5(4):715-725. PubMed ID: 34260017
[TBL] [Abstract][Full Text] [Related]
24. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
25. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
Pilz MJ; Seyringer S; Hallsson LR; Bottomley A; Jansen F; King MT; Norman R; Rutten MJ; Leeuw IMV; Siersema PD; Gamper EM
Eur J Health Econ; 2024 Mar; ():. PubMed ID: 38483665
[TBL] [Abstract][Full Text] [Related]
26. Health utility assessments in individuals undergoing diagnostic and surveillance colonoscopy: improved discrimination with a cancer-specific scale.
Bulamu NB; Chen G; McGrane E; Cock C; Young GP; Symonds EL
Cancer Causes Control; 2024 Feb; 35(2):347-357. PubMed ID: 37747615
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
[TBL] [Abstract][Full Text] [Related]
28. The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L.
Gamper EM; Cottone F; Sommer K; Norman R; King M; Breccia M; Caocci G; Patriarca A; Palumbo GA; Stauder R; Niscola P; Platzbecker U; Caers J; Vignetti M; Efficace F
J Clin Epidemiol; 2021 Sep; 137():31-44. PubMed ID: 33753228
[TBL] [Abstract][Full Text] [Related]
29. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis.
Kim H; Cook G; Goodall S; Liew D
Pharmacoecon Open; 2021 Sep; 5(3):459-467. PubMed ID: 33891268
[TBL] [Abstract][Full Text] [Related]
30. Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.
Juul T; Petersen MA; Holzner B; Laurberg S; Christensen P; Grønvold M
Qual Life Res; 2014 Oct; 23(8):2183-93. PubMed ID: 24676897
[TBL] [Abstract][Full Text] [Related]
31. The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study.
McTaggart-Cowan H; King MT; Norman R; Costa DSJ; Pickard AS; Viney R; Peacock SJ;
Health Qual Life Outcomes; 2022 Jun; 20(1):97. PubMed ID: 35710417
[TBL] [Abstract][Full Text] [Related]
32. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set.
King MT; Norman R; Mercieca-Bebber R; Costa DSJ; McTaggart-Cowan H; Peacock S; Janda M; Müller F; Viney R; Pickard AS; Cella D;
Value Health; 2021 Jun; 24(6):862-873. PubMed ID: 34119085
[TBL] [Abstract][Full Text] [Related]
33. Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer.
Bager L; Elsbernd A; Nissen A; Daugaard G; Pappot H
Health Qual Life Outcomes; 2018 Jun; 16(1):128. PubMed ID: 29914500
[TBL] [Abstract][Full Text] [Related]
34. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
King MT; Costa DSJ; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
Qual Life Res; 2016 Oct; 25(10):2683. PubMed ID: 27060088
[No Abstract] [Full Text] [Related]
35. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
de Ligt KM; Aaronson NK; Liegl G; Nolte S;
Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.
Thaysen HV; Jess P; Laurberg S; Groenvold M
Health Qual Life Outcomes; 2012 Dec; 10():150. PubMed ID: 23241096
[TBL] [Abstract][Full Text] [Related]
37. Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.
Bulamu NB; Chen G; Ratcliffe J; Schloite A; Bright T; Watson DI
World J Surg; 2019 Jun; 43(6):1554-1562. PubMed ID: 30719557
[TBL] [Abstract][Full Text] [Related]
38. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
[TBL] [Abstract][Full Text] [Related]
39. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
40. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
